Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test

This document records administrative information about the comment and notice periods for MolDX: Breast Cancer Index (BCI) Gene Expression Test LCD L37824 and contains provider comments; it does not specify clinical coverage criteria, limitations, documentation, or frequency rules. For specific coverage requirements, refer to LCD L37824 (MolDX: Breast Cancer Index) and its finalized policy text.